Abilify News

Minnesota Woman Who Lost $156,000 Files Abilify Gambling Lawsuit

A few years ago, long before she would even think about filing her Abilify gambling lawsuit, Denise Miley had what appeared to be the perfect life. She and her husband lived in a beautiful home in Maple Grove, Minnesota, with their four sons. Her career as a CPA was enjoyable [...]

By | 2017-06-20T16:11:20+00:00 May 23rd, 2017|Abilify News, Pharma News|

Bristol-Myers Squibb Will Pay $19.5 Billion in Abilify Settlement

Last month, pharmaceutical company Bristol-Myers Squibb agreed to pay $19.5 million to settle a multi-state lawsuit that charged the company with improper marketing of the atypical antipsychotic Abilify. Abilify is made by Otsuka America Pharmaceutical, Inc. and marketed and promoted in the United States by Bristol-Myers Squibb. Money from the [...]

By | 2018-07-17T12:00:22+00:00 January 20th, 2017|Abilify News, Pharma News|

U.S. Abilify Warning Label Now Includes Compulsive Gambling

The popular antipsychotic Abilify (aripiprazole) received approval from the U.S. Food and Drug Administration (FDA) in 2002 for the treatment of bipolar disorder, schizophrenia and other major depressive disorders. Since then, there have been over 180 reported instances of impulse control problems among Abilify users, including compulsive gambling, shopping, binge [...]

By | 2017-06-20T16:12:01+00:00 September 26th, 2016|Abilify News, Pharma News|